Clinical Trial: A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers

U.S., Jan. 18 -- ClinicalTrials.gov registry received information related to the study (NCT06780254) titled 'A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers' on Jan. 07.

Brief Summary: First-in-Human study to demonstrate the safety and tolerability of single- and multiple-ascending doses of MH-001 in Healthy Volunteers (HVs)

Study Start Date: Sept. 09, 2024

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: MH-001

capsules

DRUG: Placebo

capsules

Recruitment Status: RECRUITING

Sponsor: Vespina Lifesciences Inc.

Disclaimer: Curated by HT Syndication....